Although, these observations suggest that excessive Stat3 activation within the myeloid cell lineages indirectly enhances tumour progression by subverting anti-tumour immunity, the contribution of myeloid Stat3 activation to the growth of tumours that are driven by persistent epithelial Stat3 activation remains less well understood. This evidence concerns the gene STAT3 and neoplasm.